Hi all,
Just trying to get my head around the future revenues of HGR, esp in the US Workplace drug testing market.
From the HGR Investor presentation it states the market in the US for workplace testing is 133,000,000 drug tests p.a with a market size of $1.3 billion at about $10 a test.
Just trying to work out how much market share HGR can REALISTICALLY expect to gain assuming FDA approval is granted as the first .
I don't have any reason to pick a figure but if you think 10% market share then REVENUES would be
13,300,000 x lets say $8 a test = $106.4 million p.a. vs a current market cap of approx $20.4 million.
Anyway I am thinking of topping up this week - but I am interested in anyones thoughts on a target market share in US or if anyone has spoken to the company about their ambitions or goals re. US market share.
I'm not interested in ramping etc....just considered or knowledgable opinions please....mine is just a guess at 10% for purposes of trying to work out potential revenues.
I havnt even considered Mexico or Europe etc....but would be interested in peoples opinions who have more knowledge than me re. the US.
Thanks
Hevlet
- Forums
- ASX - By Stock
- HGR
- market share in usa
HGR
unknown
market share in usa
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HGR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online